Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Nov 16, 2013; 5(11): 551-558
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.551
Published online Nov 16, 2013. doi: 10.4253/wjge.v5.i11.551
Table 1 Patients’ baseline characteristics
| Characteristics | Overall | Occult-OGIB | Overt-OGIB | P value |
| Patients | 100.00% | 63.80% | 36.20% | - |
| Age [yr, median (IQR)] | 72 (5-79) | 71 (5-78) | 73 (49-82) | 0.800 |
| Gender (female) | 45.70% | 55.20% | 28.90% | 0.014 |
| Bleeding-related drugs | 41.90% | 37.30% | 50% | 0.200 |
| NSAIDs | 30.50% | 26.90% | 36.80% | 0.300 |
| Hemoglobin level [g/dL, median (IQR)] | 7.5 (6.4-9.3) | 7.4 (6.0-9.1) | 7.6 (6.5-9.4) | 0.600 |
| Transfusion requirements | 61% | 55.20% | 71.10% | 0.080 |
| Transfusion requirements (blood units, mean ± SD) | 2.01 | 1.7 ± 1.7 | 2.5 ± 2.3 | 0.037 |
| Follow-up [d, median (IQR)] | 326 (123-641) | 330 (154-691) | 217 (84-476) | 0.500 |
- Citation: Cañas-Ventura A, Márquez L, Bessa X, Dedeu JM, Puigvehí M, Delgado-Aros S, Ibáñez IA, Seoane A, Barranco L, Bory F, Andreu M, González-Suárez B. Outcome in obscure gastrointestinal bleeding after capsule endoscopy. World J Gastrointest Endosc 2013; 5(11): 551-558
- URL: https://www.wjgnet.com/1948-5190/full/v5/i11/551.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i11.551